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Structure of the initiation-competent RNA
polymerase I and its implication for transcription
Michael Pilsl1, Corinne Cruciﬁx2, Gabor Papai2, Ferdinand Krupp2, Robert Steinbauer1,w, Joachim Griesenbeck1,
Philipp Milkereit1, Herbert Tschochner1 & Patrick Schultz2
Eukaryotic RNA polymerase I (Pol I) is specialized in rRNA gene transcription synthesizing up
to 60% of cellular RNA. High level rRNA production relies on efﬁcient binding of initiation
factors to the rRNA gene promoter and recruitment of Pol I complexes containing initiation
factor Rrn3. Here, we determine the cryo-EM structure of the Pol I-Rrn3 complex at 7.5 Å
resolution, and compare it with Rrn3-free monomeric and dimeric Pol I. We observe that Rrn3
contacts the Pol I A43/A14 stalk and subunits A190 and AC40, that association re-organizes
the Rrn3 interaction interface, thereby preventing Pol I dimerization; and Rrn3-bound and
monomeric Pol I differ from the dimeric enzyme in cleft opening, and localization of the A12.2
C-terminus in the active centre. Our ﬁndings thus support a dual role for Rrn3 in transcription
initiation to stabilize a monomeric initiation competent Pol I and to drive pre-initiation
complex formation.
DOI: 10.1038/ncomms12126 OPEN
1 Universita¨t Regensburg, Biochemie-Zentrum Regensburg (BZR), Institut fu¨r Biochemie, Genetik und Mikrobiologie, Lehrstuhl Biochemie III, 93053
Regensburg, Germany. 2 Department of Integrated Structural Biology, IGBMC (Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire) INSERM,
U964; CNRS/Strasbourg University, UMR7104 1, rue Laurent Fries, BP10142, 67404 Illkirch, France. w Present address: Sandoz GmbH, Biochemiestrae 10,
6250 Kundl, Austria. Correspondence and requests for materials should be addressed to H.T. (email: herbert.tschochner@ur.de) or to P.S.
(email: patrick.schultz@igbmc.fr).
NATURE COMMUNICATIONS | 7:12126 | DOI: 10.1038/ncomms12126 | www.nature.com/naturecommunications 1
A
lthough all of the nuclear RNA polymerases share
common features in composition and basic transcrip-
tional mechanisms1,2, they are highly specialized to
recognize and speciﬁcally transcribe their target genes3,4. In
most eukaryotes RNA polymerase I (Pol I) recognizes only one
promoter and synthesizes a large precursor transcript which is
processed into the mature 5.8S, 18S and 25/28S ribosomal RNAs
(rRNAs). Initiation at the Pol I promoter requires several basal
transcription initiation factors. In the yeast S. cerevisiae these are
the TATA-binding protein (TBP), and the Pol I-speciﬁc factors as
Rrn3 (ref. 5), the core factor (CF) which contains the three
subunits Rrn6, Rrn7 and Rrn11 (refs 6,7), and the upstream
activating factor (UAF) consisting of Rrn5, Rrn9, Rrn10, the
histones H3 and H4 and UAF30 (refs 8,9). CF, TBP and UAF
provide a promoter-bound platform to which a complex of Pol I
with Rrn3 is recruited5,10. Several aspects of Pol I transcription
initiation are conserved between yeast and mammals.
Conservation in sequence and function is observed for TBP,
Rrn3/TIFIA and Pol I (ref. 11,12) (reviewed in ref. 1).
Mammalian SL1 and yeast CF share some functional and
structural properties6,13,14. Importantly, complex formation of
Pol I with Rrn3 was identiﬁed as a regulated key step in yeast and
mammalian Pol I transcription initiation (reviewed in ref. 15). In
yeast, cellular extracts o55% of Rrn3 and o5% of Pol I were
estimated to be incorporated in the salt-stable initiation
competent Pol I-Rrn3 complex10,16,17. This suggested that only
a subpopulation of Pol I is compatible with complex formation.
When Pol I switches from initiation to elongation, the Pol I-Rrn3
complex is disrupted10,16,18,19. The Pol I subunit A43 was shown
to be crucial for Pol I-Rrn3 complex formation. Mutations in the
central part of A43 abolished Pol I-Rrn3 complex formation,
resulted in a temperature sensitive growth phenotype and
fractions containing mutated Pol I failed in transcription
initiation20. Furthermore, the non-essential subunit A49
contributes to the recruitment of Pol I-Rrn3 to the promoter
and plays a role in Rrn3 release from the polymerase after
promoter clearance19. Although there is evidence that the
formation of the Pol I-Rrn3 complex might depend on
posttranslational covalent modiﬁcations in vivo21,22, the
molecular requirements for Rrn3-Pol I interaction remain to be
deﬁned. Previously, a model of the interaction interface between
the transcription factor and the polymerase has been
proposed22,23. This model was based on the crystal structure of
Rrn3 (ref. 22), on a Pol I homology model24 and on two BS3 (bis-
sulfosuccinimidyl-suberate) crosslinks between Rrn3 Lysine K558
and Lysines K582 and K329 of the Pol I subunits A190 and AC40,
respectively. Thus, it was suggested that the serine patch of Rrn3
is oriented towards the Pol I surface, and Rrn3 stretches from the
RNA exit tunnel down to subunits AC40/19, while contacting
subunits A43/14 with its central part22.
Recently, the crystal structure from Pol I dimers provided
insights in the architecture of the enzyme at atomic resolu-
tion25,26. Interestingly, direct comparison with the Pol II structure
showed several differences, some of which are probably a
consequence of Pol I dimerization. The C-terminal part of A43,
‘the connector’ domain, invades between the clamp and the
‘protrusion’ domains of the neighbouring Pol I molecule. It is
possible that this stable interaction contributes to signiﬁcant
widening of the nucleic acid binding ‘cleft’, when compared with
the corresponding structure in Pol II. The wider cleft
accommodates an extended Pol I speciﬁc ‘expander’ loop,
which mimics the DNA backbone. The absence of the expander
loop in the opened cleft of some (dimeric) crystal structures26,27
suggests that the expander loop is a mobile domain. Other
possible consequences of the widened cleft could be that the
‘bridge helix’ in the active centre is unwound26, and that the
C-terminal domain of subunit A12.2 is inserted into the
nucleotide triphosphate entry pore. The C-terminal domain of
A12.2 is homologous to the C-terminus of TFIIS adopting a
similar structure in the active centre of a Pol II-TFIIS complex,
which is transcriptionally stalled after backtracking28–30. The
inserted C-terminus of TFIIS stimulates RNA cleavage to resume
Pol II-dependent RNA chain elongation.
The transition from a dimeric and expanded inactive
conformation into a more contracted, initiation-active monomeric
conformation was suggested to play a role in Pol I transcription
regulation25. In this model, Pol I is in an equilibrium of dimers and
monomers. Monomer formation requires the reorientation of the
connector. Monomers are thought to be inactive until the release of
the expander, perhaps due to DNA loading and cleft contraction.
Monomerization also provides the interface for association with
Rrn3 and Rrn7 (ref. 25).
In summary, the high-resolution structures of the Pol I
enzyme25,26 and Rrn3 (ref. 22) provided important insights into
the molecular architecture of the rRNA synthesizing machinery.
Here, the structure of the yeast Pol I-Rrn3 complex is solved by
single-particle electron cryo-microscopy at 7.5 Å resolution, and
strongly support the previously suggested interaction interface
between Rrn3 and Pol I (ref. 22). Additionally, several differences
to the Pol I crystal structures are detected, which correlate with
the initiation competence of the monomeric complex. These
include changes in the active centre of Pol I like the
re-organization of the expander, and the displacement of the
A12.2 C-terminal domain together with closing of the cleft.
Furthermore, cryo-electron microscopy (cryo-EM) detects a
not fully assigned density over the cleft, which may correspond
to the domain of A49 not resolved in the high-resolution
structures. The position of the presumed A49 domain is in good
agreement with earlier ﬁndings31,32. The use of a minimal
promoter-dependent in vitro transcription system supports a
role for the tandem winged-helix (tWH) domain of A49 in
transcription initiation and elongation in line with its suggested
functional roles19,24,33.
Results
Puriﬁed initiation-competent yeast Pol I-Rrn3 complex.
Initiation of Pol I transcription in yeast cell extracts depends on
the formation of a salt resistant complex between Pol I and the
initiation factor Rrn3 which was previously described as initiation
competent Pol I (ref. 10). In yeast whole-cell extracts, the Pol
I-Rrn3 complexes represent only a minor population of total
cellular Pol I. We have recently described a puriﬁcation protocol
to obtain highly enriched Pol I-Rrn3 complex, which, together
with recombinant CF, was active in a minimal promoter-depen-
dent transcription system34. The protocol for isolation of the
stable Pol I-Rrn3 complex could be further improved (Methods
section), yielding a complex consisting of almost stoichiometric
amounts of Pol I subunits and Rrn3 (Fig. 1a, ﬁrst panel). A
similarly prepared yeast extract from a different strain served as
source to purify a Pol I complex, which was largely devoid of
Rrn3 (see Methods section, Fig. 1a, second panel). Incubation of
Rrn3-free Pol I with over-stoichiometric amounts of puriﬁed
recombinant Rrn3 and CF (Fig. 1a, last panel) resulted in
promoter-dependent transcription, whereas no transcript was
detected in reactions lacking either one of the components
(Supplementary Fig. 1; see also Fig. 6b, lanes 13–15). The optimal
amount of Rrn3 at a given concentration of Pol I and CF was
determined in titration experiments (Supplementary Fig. 2).
Comparison of the transcriptional activity of the two Pol
I-containing fractions showed clear differences when the same
concentration of Pol I and Pol I-Rrn3 and optimized amounts of
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CF and Rrn3 were used (Fig. 1b). Whereas Rrn3-free Pol I
produced higher amounts of RNA in promoter-independent
transcription from tailed templates, the Pol I-Rrn3 complex was
up to 10-fold more active in promoter-dependent transcription
(Fig. 1b). This result suggested that complex formation between
Rrn3-free Pol I and recombinant Rrn3 in vitro was poor under
the conditions used in this study. The successful puriﬁcation of
the initiation competent Pol I-Rrn3 complex from yeast extracts
encouraged us to study its three-dimensional (3D)-structure
using cryo-EM.
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Cryo-EM structure of the Pol I-Rrn3 complex. A total of 49,583
molecular images of the frozen hydrated, glutaraldehyde cross-
linked Pol I-complexes were collected and sorted to separate free
Pol I from intact complexes (32,438). The reﬁned 3D model of
the Pol I-Rrn3 complex was solved at an overall resolution of
7.5 Å. This allowed to visualize secondary structure elements of
the enzyme and its associated cofactor and enabled precise
docking of their independently determined atomic structures into
the cryo-EM map22,25,26 (Fig. 2a, Supplementary Fig. 3). The
elongated Rrn3 molecule interacts through its N-terminus with
the A43/A14 ‘stalk’, contacts the ‘dock’ region of subunit A190
and reaches the AC40 and AC19 subunits with its C-terminal end
as suggested by cross-linking and homology modelling data22,23.
While the position of the A14 subunit is not affected when its
residues 83–85 interacts with residue 224 of Rrn3, the A43
subunit is reorganized upon interaction (Fig. 2b). The bundle of
beta strands forming the oligonucleotide/oligosaccharide-binding
‘OB’ fold (residues 127–251) and the N-terminal ‘tip’ domain of
A43 are not affected, while residues 274–316 of A43 are not
detected and are probably re-positioned on Rrn3 binding
(Supplementary Fig. 4). These residues encode the connector
helix which is an essential determinant of Pol I dimerization25–27,
suggesting that the binding of Rrn3 interferes with dimer
formation. Finally, the Rrn3 serine-patch identiﬁed as
important for Pol I binding22 is involved in the interface.
The helix-forming residues 243–251 of Rrn3 contact the ‘dock’
domain of the largest A190 subunit and particularly helix
549–564 and residues 564–573 which are part of the Pol I-speciﬁc
region a12a (Fig. 2c). Finally, the end of helix-forming residues
554–542 of Rrn3 are in close contact with C-terminal and
N-terminal loops of AC40 (residues 334) and AC19 (residues
44–49), respectively (Fig. 2d). This is consistent with cross-linking
data using BS3 (bis-sulfosuccinimidyl-suberate), which identiﬁed
with high conﬁdence a contact between lysine 558 of Rrn3 and
AC40 lysine 329 and A190-lysine 582, respectively22
(Supplementary Fig. 5).
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Figure 2 | Cryo-EM structure of the Pol I-Rrn3 complex. (a) Atomic structure of Pol I (red, PDB accession numbers 4C2M (ref. 25) and 4C3H (ref. 26))
and of Rrn3 (blue, PDB accession number3TJ1 (ref. 22)) docked into the cryo-EM structure of the Pol I-Rrn3 complex (transparent yellow envelope).
Regions enlarged in b–d are highlighted. Arrow head shows the weak density bridging the cleft poorly visible at this threshold. (b) Close-up view of the Pol
I-Rrn3 complex showing the interaction of the N-terminus of Rrn3 with the A43-A14 stalk. The C-terminal part of A43 (residues 273–316, shown in green)
is displaced on Rrn3 binding. (c) Close-up view of the Pol I-Rrn3 complex on the central domain of rrn3 interacting with the dock domain of the largest Pol I
subunit A190 containing the Pol I-speciﬁc region a12a (green). (d) Enlarged view of the Pol I-Rrn3 complex showing the interaction of the C-terminus of
Rrn3 (blue) with the N- and C-terminal loops of AC40 (green).
Figure 1 | Puriﬁed Pol I-Rrn3 complex from yeast whole-cell extracts is more active in transcription initiation than puriﬁed Pol I complemented with
bacterially expressed Rrn3. (a) Protein fractions used for either transcription initiation in a minimal promoter-dependent transcription assay or in non-
speciﬁc (tailed template) transcription. Proteins were separated by SDS–PAGE using a 4–12% gradient gel which was stained with SimplyBlue SafeStain
(ThermoFisher). Pol I was afﬁnity puriﬁed from strain BY4741 A135-TEV-ProtA (y2423) using a ProtA-TEV-tag fused to subunit A135 (see Materials and
Methods). Puriﬁed Pol I (10mg) were loaded. Molecular weight standards (M) and Pol I subunits which were identiﬁed by mass spectrometry are indicated.
Pol I-Rrn3 complex was derived from yeast strain y2183 (BSY420-Rrn3-TEV-ProtA-His7-Tag) which was transformed with plasmid 729 (Ycplac111-GAL-
Rrn3-TEV-ProtA-HIS). This strain overexpresses Rrn3 in the presence of galactose. The complex was afﬁnity puriﬁed from the initiation-active fraction
PA600 (ref. 17) using a ProtA-TEV-tag fused to Rrn3 (Materials and methods section). Pol I-Rrn3 complex (6mg) were loaded. Recombinant Rrn3 (rec
Rrn3) and CF (rec CF) were expressed in E. coli and puriﬁed according previously published protocols22,48 with some modiﬁcations (Materials and methods
section). MonoQ elution fraction (10 ml) of Rrn3 and 11ml of a Superose 6 elution fraction of CF respectively, were separated on a 10% SDS-gel and
Coomassie stained. (b) Comparison of differently derived Pol I fractions in promoter-dependent and non-speciﬁc transcription assays (10 nM template
concentration, end point labelling after 30min). Rising concentrations of Pol I or Pol I-Rrn3 complex (concentrations in the assays are indicated) were
assayed together either with recombinant His6-Rrn3 (70 nM) and CF (20nM) or CF (20 nM) in promoter-dependent transcription (left panel). The same
concentrations of Pol I and Pol I-Rrn3 were used in non-speciﬁc transcription assays (middle panel). A quantitative comparison of the two different Pol I
fractions (4 nM) in the two transcription assays is indicated on the right.
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Fitting Pol I into the Pol I-Rrn3 cryo-EM model. Interestingly,
signiﬁcant changes were observed in the structure of Pol I. The
active centre cleft is more contracted in the cryo-EM map than in
the crystal structure. The displacement vector ﬁeld obtained by
comparing the crystal form with the normal mode ﬁtted version
shows that the ‘clamp’ domain and the A43-A14 stalk moved
inwards (Fig. 3a). The two long helices that form the clamp core
domain of A190 are displaced by 8Å. (Supplementary Fig. 4a).
On the other side of the DNA-binding cleft an inward movement
of 3.5 Å is also measured at the tip of the ‘protrusion’ domain of
A135, indicating that the cleft closes by 11.5 Å when compared
with the crystal structures. In addition, the C-terminal part of
A12.2, which holds the TFIIS homology region, is absent in the
cryo-EM map while it is positioned in the pore in the crystal
structure (Fig. 3b). Interestingly, A12.2 is not dissociated from Pol
I since the N-terminal part, homologous to Rbp9, including two
helices is perfectly resolved and is located similar to its position in
the crystal structure (Fig. 3b). This observation indicated that the
C-terminal domain of A12.2 dissociates from the active site and is
probably ﬂexible since no similar density was detected in the map.
Another important difference to the crystal structure is found
within the active site. While all helices are resolved, no density is
observed for the Pol I-speciﬁc expander domain and the expander
helix, an element present in the active site in several crystal
structures (Fig. 3c)25,26. The fact that the expander helix/extended
loop is missing in some crystal forms26,27 and could not be traced
in the electron density map suggests that it is ﬂexible. Finally, we
observed that the A190 ‘lid loop’ (residues 368–380) is perfectly
resolved in the EM map, but its position within the RNA exit
channel is slightly shifted (Fig. 3d), suggesting that the RNA exit
channel is less occluded than in the Pol I crystal structure.
When the threshold is lowered, a weak density can be detected
over the cleft bridging the clamp to the ‘protrusion’ domain,
suggesting that this bridge is present in only a subpopulation of
Pol I molecules (arrow head in Fig. 2a). The position of this
bridge is consistent with the proposed location of the mobile
C-terminal tWH domain of A49 determined by chemical cross-
linking and mass spectrometry32 and could correspond to the
A49 position determined previously by immuno-EM (ref. 31).
Rrn3-free Pol I monomers differ from Pol I dimers. To
ascertain the exact contribution of Rrn3 to the observed changes
in Pol I structure, we analysed the structure of puriﬁed Rrn3-free
Pol I, which was found in a monomeric form for which high-
resolution information was not available and as dimers as in the
crystal structures. In solution, the two forms co-exist and the
monomers (108.214 particles 28%) were separated from the
dimers (141,024 particles 72%) in silico. At a resolution of 7.5 Å,
the isolated Pol I monomer structure was very similar to the
Rrn3-bound enzyme (Supplementary Fig. 6). In particular, the
C-terminal domain of A12.2 is not detected, whereas it is present
in the centre of the dimer (Fig. 4a,d,g; Supplementary Fig. 7) and
the position of the clamp is almost identical in both structures
indicating that the cleft has the same width. The lid loop was
positioned slightly differently than in the crystal structure but still
in a way that it partly occludes the RNA exit channel (Fig. 4c,f,i).
The expander helix was clearly not in the same position as in the
A135
protrusion
A190 extended
clamp coiled-coil
c
d
b
A190 expander helix A190 lid
A12.2a b
c d
Figure 3 | Structural changes of Pol I in the Rrn3-bound conformation as compared with the crystal form. (a) Flexible ﬁtting of the atomic structure of
Pol I into the cryo-EM structure of the Pol I- Rrn3 complex. The displacement vectors (red) associated to each residue when moving from the crystal
structure (blue) to the cryo-EM model show the closing of the cleft and the upward movement of the A43-A14 stalk. Structural regions enlarged in b–d are
highlighted by circles. (b) Crystal structure of the A12.2 subunit (green) whose C-terminal TFIIS-like domain is not located in the pore of the Pol I-Rrn3
cryo-EM structure. (c) Crystal structure of the expander helix (green) of the A190 subunit (residues 1,361–1,378) which is not resolved in the cryo-EM
structure. (d) Position of the lid loop of subunit A190 (residues 368–380) in the crystal structure (green ribbons) as compared with the cryo-EM structure
(green envelope).
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early crystal structures but a new density is placed in the active
site which could correspond to a different position of the
expander domain (Fig. 4b,e,h). The monomeric Pol I form seems
to be slightly depleted in A49/34.5 since the corresponding
density is weaker than in the Pol I-Rrn3 complex, but the bridge
over the cleft is detected as a faint electron density (data not
shown). Altogether, this comparison indicated that the major
conformational changes in Pol I are not speciﬁc for the Rrn3-
bound complex, but rather properties of monomeric Pol I.
Similar cryo-EM and crystal structures of Pol I dimers. The
analysis of the dimeric Pol I form by cryo-EM was important to
understand the differences with the crystal structures
(Supplementary Fig. 8). A ﬁnal resolution of 7.8 Å was obtained
for the entire dimer, which shows a slight movement between the
two monomers. This could be partially corrected by analysing a
single monomer thus reaching a resolution of 6.8 Å. The A43-A14
stalk is essential for dimerization and the stalk of one monomer
interacts with the DNA-binding cleft of the second monomer.
The connector helix in A43 plays a crucial role for dimerization
and contacts the ‘protrusion’ domain of A135 close to the Pol
I-speciﬁc insertion a11a. Whereas, the A43 connector helix is
poorly resolved in the monomeric form of Pol I, and is displaced
on binding of Rrn3, it is perfectly resolved in the dimer at the
position determined by X-ray crystallography (Supplementary
Figs 6 and 8). Moreover, the cryo-EM dimer map is comparable
to the crystal structure with regard to cleft opening, and for the
density corresponding to the C-terminal domain of A12.2, which
is clearly detected at the same position (Fig. 4g). However, the
expander helix observed in some of the crystal structures, is not in
the same position, while a new density appears in the active site as
seen for the isolated monomer (Fig. 4h). Interestingly, in all three
structures the catalytically important ‘bridge’ helix appeared to be
partially unwound in its central part, indicating that even when
the expander helix is absent the bridge helix does not fold
properly (Supplementary Fig. 9). The A190 lid loop is well
resolved in the cryo-EM dimer map and it adopts the same
position than in the crystal form (Fig. 4i). Furthermore, the
density bridging the DNA-binding cleft is weakly detected in all
maps suggesting that the corresponding protein domain is not
stably positioned.
The C-terminal domain of A49 spans the Pol I cleft. To better
deﬁne the spurious density detected in all the cryo-EM maps
above the DNA-binding cleft, we analysed the density variations
within the dimer-forming monomers by 3D classiﬁcation. This
analysis revealed a protein density, which can adopt different
positions. The most abundant conformation, representingB35%
of the molecules, depicts this domain more clearly (Fig. 5a)
although residual ﬂexibility hindered resolving secondary struc-
ture elements. This additional density occupies a volume of
B17 kDa, which is consistent with the mass of the tandem
winged domain (tWD) of A49. This domain was not resolved in
the crystal structures and has been shown to cross-link to both
sides of the cleft32. The density bridging the cleft contacts several
Pol I-speciﬁc sequences not found in Pol II: the two regions
ﬂanking the A190 expander domain (residues 1,320–1,337 and
1,440–1,456), the A190 clamp head domain (residues 56–303)
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Figure 4 | Comparison of key structural features in different Pol I conformational states. The position of the A12.2 C-terminus (a,d,g) the A190
expander helix (b,e,h) and the A190 lid loop (c,f,i) are shown in the cryo-EM maps of the Pol I- Rrn3 complex (a–c) the Pol I monomer (d–f) and the Pol I
dimer (g–i).
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and a small loop in the A135 lobe domain (residues 222–226;
Fig. 5b). The density also contacted two helices in subunit ABC27
(residues 87–123). The atomic structure of the A49 tWD domain
could be ﬁtted in size and shape into this additional density thus
conﬁrming that it likely corresponded to the C-terminus of A49
(Fig. 5b). The lower resolution of this part of the cryo-EM map
did not provide sufﬁcient secondary structure information to
conﬁrm the ﬁtting. In this position, the set of distance constraints
obtained from cross-linking data were minimized and 50% of the
observed cross-linked lysines were within 30Å (ref. 32). However,
for the other half of the reported intersubunit crosslinks, the
concerned lysines are further apart, an observation that probably
reﬂected the ﬂexibility of this domain.
The C-terminal domain of A49 supports initiation in vitro. The
localization of the presumed A49 C-terminus would be compa-
tible with previous data31,32 which showed its involvement in
DNA binding and transcription elongation but also with the
suggested TFIIE-like function in initiation of Pol I transcription.
Therefore, we re-analysed the role of the C-terminal domain in
the promoter-dependent in vitro transcription system (Fig. 6). Pol
I lacking subunits A49/34.5 (Pol I D49) was almost inactive when
compared with wild-type (WT) Pol I in promoter-dependent
transcription (Fig. 6a, compare lane 6 with lanes 7 and 8).
Addition of recombinant A49/34.5 dimer stongly stimulated
transcription. In contrast, Pol I D49 was more potent in tailed
template transcription, while the addition of A49/34.5 dimer
showed only moderate stimulation in this assay. This is in line
with in vitro data that the A49/34.5 dimer supports Pol I
processivity24,33 and with in vivo data for a role in transcription
initiation and elongation19. Consistent with previous
analyses19,33, addition of the A49 tWH domain alone to Pol I
D49 was sufﬁcient to restore promoter-dependent and tailed
template transcription to a similar level as observed for the
addition of recombinant A49/34.5 dimer (Fig. 6b), whereas
addition of the A49/34.5 dimerization module had no effect.
These results further point to a role of the A49 tWH domain for
both, Pol I transcription initiation and processivity.
Altogether, these results showed that the monomeric Pol I
structure derived from cryo-EM analyses did not signiﬁcantly
differ from the Pol I-Rrn3 complex. This underlined that Rrn3
association was not required for cleft closing and removal of both
the expander helix and the A12.2 C-terminus from the active
centre. In contrast to free Pol I molecules, Pol I-Rrn3 complexes
existed only as monomers consistent with the observation that
Rrn3 binding interfered with Pol I dimerization mediated by A43.
To ﬁnd out whether Rrn3 incubation triggered monomerization
of dimeric Pol I, increasing amounts of Rrn3 were incubated with
a fraction containing both monomeric and dimeric Pol I
(Supplementary Table 4). In comparison to control reactions
without Rrn3, only a subtle shift in the populations towards more
Pol I monomers could be observed. The ratio of monomers and
dimers did not signiﬁcantly change even after an incubation time
for 2 h with a 10-fold excess of Rrn3. This suggested that only a
minor subpopulation of Pol I associates with Rrn3, which is
supported by previous published studies10,16 and the result of
in vitro transcription experiments presented in the present study
(see Fig. 1b and Supplementary Fig. 2). Overall, our ﬁnding
supported previous studies, suggesting that structural, yet
unknown features of Pol I, other factors or experimental
conditions were required for dimer dissociation and Rrn3-
binding17,21.
Discussion
The general structural arrangement of the Pol I-speciﬁc initiation
factor Rrn3 on the Pol I core analysed in this study was as
A135
lobe
A190
Clamp head
90°
90°
ABC23
A190 expander
domain
a
b
Figure 5 | The A49 tWD bridges the DNA-binding cleft. (a) Protein density (purple) found in a subpopulation of Pol I molecules. (b) Proposed ﬁt of the
A49 tWD (PBD accession number 3NFI (ref. 33)) within this density. Residues in contact with the A49 tWD are highlighted in red and correspond to the
A190 clamp head domain (residues 256–303), the Pol I-speciﬁc regions ﬂanking the A190 expander domain (1,320–1,337 and 1,440–1,456), a Pol I-speciﬁc
region in the A135 lobe domain (residues 222–226) and the ABC23 subunit (residues 87–123).
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predicted from cross-linking approaches and modelling of the
Rrn3 crystal structure into the homology Pol I/Pol II model22,23.
Accordingly, Rrn3 is oriented towards subunit A43 making
contacts via the Rrn3 serine patch, and stretches along subunits
A190 and A135 down to subunit AC40/19 (ref. 22). The
orientation of Rrn3 towards the OB fold of subunit A43 is in
accordance with previous genetic, biochemical as well as with
previous EM data20. In this position, Rrn3 can bridge between Pol
I and the C-terminus of the CF subunit Rrn6 as it was previously
suggested23. Another consequence of Rrn3 binding is the
re-organization of the A43 C-terminus and the interference
with Pol I dimerization by displacing the Pol I–Pol I interaction
through the connector helix. Dimer dissociation is important for
the structural rearrangements yielding initiation competent Pol I.
Interestingly, Rrn3 resembles the Mediator of Pol II transcription
head domain in its structure as well as in its interaction with the
respective polymerase stalk22,35,36. Thus, the comparative
structural analysis of Pol I and Pol II may reveal common
principles in pre-initiation structure and formation.
The crystal structures of Pol I and Pol II revealed some clear
differences, which can be due to the specialization of the enzymes
for transcription or an artefact of the particular requirements for
crystallization. The most signiﬁcant differences were that Pol I
has an B10Å more open cleft, an extended loop (expander) in
the cleft, which might mimic DNA and an active centre, which
resembles a reactivated backtracked polymerase28,30.
Furthermore, Pol I crystallized as a dimer in which the
C-terminal part of subunit A43 (expander helix) reaches into
the cleft of a neighbouring Pol I molecule. Many of these features
suggested that Pol I has to undergo conformational changes to
initiate transcription. The determination of the cryo-EM
structures for Pol I-Rrn3 (and Rrn3-free Pol I) is one further
step to understand the formation of the Pol I pre-initiation
complex.
The cryo-EM structure of the dimeric form of Pol I strongly
resembles the Pol I crystal structure. The structures of Rrn3-Pol I
and the Rrn3-free monomeric form of Pol I, in contrast, are more
compatible with a transcriptional active enzyme. The cleft is
closed by about 11Å and neither the expander loop, nor the
A12.2 C-terminus are found in the active centre. The position of
the expander loop seen in some of the crystal structures may
hamper interaction with the template. In contrast to Pol II,
puriﬁed Pol I needs over-stoichiometric amounts of tailed
template for efﬁcient RNA synthesis in vitro25. This might
point to the possibility that excess template is required to displace
the expander loop (and the C-terminal domain of A12.2 (see
below)) from the active centre, thereby converting inactive Pol I
into a more transcription competent Pol II-like conformation.
Our data suggest that Pol I may adopt a conformation, which is
likely compatible with transcription even in the absence of DNA.
The interaction between Pol I and Rrn3 could either stabilize or
induce such structural changes (see also discussion below).
In the Pol I crystal structure the TFIIS-like C-terminal domain
of A12.2 occupied the active centre in the crystal structure. Its
position is very similar to that of TFIIS in Pol II after
backtracking when TFIIS stimulates intrinsic Pol II cleavage of
the 30 RNA extension28,30. Our cryo-EM analyses revealed that, in
analogy to the homologous Pol III subunit C11 (ref. 37) and the
Pol II factor TFIIS (refs 28,30), the C-terminal domain of A12.2 is
not an integral part of the active centre, and that it can be
removed from its position in the nucleotide entry pore. However,
in contrast to Pol II, and similar to C11, the RNA cleavage-
supporting polypeptide chain is tightly associated with Pol I as
another example for ‘built-in transcription factors’ in the
enzyme24,33. Similar to TFIIS this might help to remove stalled
transcription complexes more efﬁciently38, thus increasing
processivity39,40. Consistently, Pol I recovers mostly by RNA
cleavage for backtracks larger than 3 nt, whereas Pol II without
nM 4 4 12 4 12 4 12 4 124
+ A49/34.5 + A49/34.5
WT WTΔ49 Δ49
Tailed template Promoter template
4 nM Δ49
Tailed template Promoter template
Promoter
transcript 
a b
+ 
A4
9/3
4.5
+ 
Nt
 
A4
9/3
4.5
+ 
Ct 
A4
9
+ 
A4
9/3
4.5
+ 
Nt
 
A4
9/3
4.5
+ 
Ct 
A4
9
+ + + + + + + + + + + +
Tailed template
transcript 
1 52 3 4 6 7 8 9 10 11 121 52 3 4 6 7 8 9 10
100% 2±1 5.2±1.4 100 < 0.2 2.9±1
Figure 6 | The A49/34.5 dimer and the C-terminal part of subunit A49 are required for transcription initiation and support non-speciﬁc transcription.
(a) Recombinant subunit A49/34.5 can complement for the transcription defect of Pol I DA49. Tailed template assays and promoter speciﬁc transcription
were performed using 4 or 12 nMWT Pol I or DA49 Pol I in the presence and absence of puriﬁed recombinant A49/34.5 heterodimer. Promoter-dependent
assays were performed in the presence of 70 nM Rrn3 and 20 nM CF. Note that radiolabelled transcripts can be clearly seen in tailed template transcription
using Pol IDA49 after longer exposure, whereas no transcripts can be detected in promoter-dependent assays. (b) The C-terminus of A49 is sufﬁcient to
complement for initiation in a minimal transcription system which is dependent on recombinant CF, Rrn3 and puriﬁed Pol I DA49. Same experimental
outline as in a, but transcription was analysed in the presence of the puriﬁed C-terminal domain of A49 (residues 111–426) or the coexpressed N-terminal
domain of A49 (1–181) and A34.5 (Materials and methods section).
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TFIIS uses also 1-D diffusion to regain transcription elongation.
The ‘built-in’ cleavage activity may prevent frequently ocurring
transcriptional arrests which would be especially disadvantagous
for the highly transcribed rRNA genes of fast dividing cells41.
Another dynamic module, which appears to be involved in
transcription initiation, is the C-terminal tWH domain of subunit
A49. This domain structurally resembles the Pol II transcription
initiation factor TFIIE (ref. 33). Ectopic expression of the tWH
domain was sufﬁcient to suppress impaired Rrn3 and Pol I
recruitment to the rRNA gene in A49 deletion strains19. Our
in vitro data are compatible with a role of the tWH domain in
rDNA transcription initiation, although it also enhanced
transcript elongation from a tailed template. The position of the
tWH domain was not resolved in the Pol I crystal structure, but
the cryo-EM data in this study together with previous immuno-
EM (ref. 31), and cross-linking analyses23,32 indicate that it forms
a bridge over the DNA-binding cleft. The structure of the entire
A49/34.5 heterodimer strongly resembles the structures of the Pol
II transcription factors TFIIF and TFIIE, and indicates that they
may have similar functions33. The cryo-EM data are in line with
the assumption that the tWH domain is mobile and likely needs
to be displaced to allow access of the promoter DNA to the Pol I
active site.
The interesting concept of ‘built-in transcription factors’
appears to be a general feature for yeast Pol I and Pol III systems
(reviewed in ref. 2). Thus, instead of relying on limiting factors
such as TFIIS, TFIIE or TFIIF functional counterparts have been
incorporated in the enzymes in form of stably associated bona
ﬁde polymerase subunits (for example, A12.2, A34.5 and A49 in
case of Pol I). This feature might be the reason for the
extraordinary efﬁcient transcription initiation of RNA
polymerases I and III.
One remaining signiﬁcant difference within the active centre of
Pol II when compared with the active centres of the three
different cryo-EM structures of Pol I (Pol I dimer, Pol I monomer
and Pol I-Rrn3) is the conformation of the bridge helix. For Pol II
a mechanism was proposed in which a switch between a partially
unfolded and a completely folded bridge helix and the resulting
bending is important for DNA, and the DNA/RNA hybrid
translocation42,43. For Pol I it was proposed that the partially
unfolded bridge helix is a consequence of the signiﬁcantly wider
cleft26. Thus, it was predicted, that cleft closing might induce
complete folding of the bridge helix and opening of the RNA exit
channel with concomitant inside movement of A135 domains26.
This structural rearrangement would be necessary for anchoring
of the transcription bubble. Whereas the latter two transitions can
be seen in the initiation competent Pol I-Rrn3 complex and the
Rrn3-free Pol I monomers, the bridge helix remained partially
unfolded in all cryo-EM structures. It is possible that DNA
binding is required for the complete folding, or that the unfolded
bridge helix is a Pol I-speciﬁc feature. In fact, exchange of two
amino acids, which change the amino acid sequence of Pol I
bridge helix into the amino acid sequence of the Pol II helix, led
to alterations of transcription speed and processivity in the
respective Pol I mutant (M.P. and H.T. unpublished
observations). This indicated that the Pol I-speciﬁc bridge helix
is important for proper Pol I activity.
Currently it is not known whether different subpopulations of
Pol I monomers and dimers exist in vivo. It is, however, tempting
to speculate that these two different forms of Pol I are involved in
Pol I transcription regulation as it was previously sug-
gested17,20,25. It is possible that Pol I dimers are a stable storage
pool for the enzyme, which is kept in an inactive state. In
response to changes in physiological situations, the pool of Pol I
dimers could be quickly activated into monomers to adjust
cellular ribosome biosynthesis. Regulatory processes like
phosphorylation, DNA-association or binding of a transcription
factor might be involved in this transition. According to our data,
the presence of Rrn3 alone is not sufﬁcient to trigger formation of
Pol I monomers. However, it is possible that Rrn3 in addition to a
yet unknown activity is required for dimer dissociation. Binding
of Rrn3 might stabilize Pol I monomers resulting in a salt
resistant initiation competent Pol I-Rrn3 complex44. At which
stage of complex formation Rrn3 stabilizes the monomeric form
remains to be unravelled. Future experiments are also necessary
to elucidate the trigger and the mechanism for monomerisation
and Pol I activation as well as the physiological relevance of Pol I
dimers.
Methods
Yeast strains, plasmids, oligonucleotides and construction of transcription
templates. Yeast strains, plasmids and oligonucleotides used in this work are listed
in Supplementary Tables 1, 2 and 3. Molecular biological methods and transfor-
mation of yeast cells were performed according to standard protocols45–47. The
generation of transcription templates is described in the supporting information.
Puriﬁcation of transcription factors and Pol I subunits. All factors were
expressed in E. coli and puriﬁed according to protocols published in ref. 22 for
Rrn3 and (refs 23,48) for CF and ref. 33 with some modiﬁcations.
Puriﬁcation of Rrn3. Rrn3 was expressed as an N-terminal His-tag fusion protein
in E. coli and puriﬁed according to ref. 22 with some modiﬁcations. Cells were lysed
by sonication. The cleared lysate was loaded on Talon afﬁnity resin (Clontech)
equilibrated with Rrn3 lysis-buffer (50mM HEPES/KOH; 10% glycerol; 200mM
KCl; 5mM MgAc2; 5mM b-mercaptoethanol; and 5mM imidazole). Beads were
washed with Rrn3 lysis-buffer and protein was eluted with Rrn3 elution buffer
(50mM HEPES/KOH; 10% glycerol; 200mM KCl; 5mM MgAc2; 5mM b-
mercaptoethanole; and 150mM imidazole). Eluate was loaded onto an anion-
exchange column (MonoQ 5/50 GL; GE heathcare) and eluated with an linear
gradient from 20 to 80% buffer B; buffer A: (20mM HEPES/KOH; 10% glycerol;
1mM MgAc2; 5mM dithiothreitol (DTT)), buffer B: (20mM HEPES/KOH; 10%
glycerol; 1mM MgAc2; 5mM DTT; and 1M KCl). Each sample taken during the
puriﬁcation process was analysed via SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) to monitor the puriﬁcation success and the protein concentration in
the elution fraction was determined.
Puriﬁcation of CF. CF subunits were coexpressed in E. coli and puriﬁed based on
the procedures published by refs 23,48. Expression vector was a kind gift from B.
Knutson. In brief, Recombinant CF protein was expressed by autoinduction in TB
medium (1.2% tryptone; 2.4% yeast extract; 0.5% glycerol; 1/10 volume of a sterile
solution containing 0.17M KH2PO4 and 0.72M K2HPO4 and 1/50 volume of a
sterile solution containing 25% glycerol; 10% lactose and 2.5% glucose were added.)
as described in ref. 49. A culture was grown at 37 C to an OD600 ofB0.6, after
cooling the culture on ice, incubation was continued at 25 C overnight. Cells were
harvested (6,000g; 10min), resuspended in CF lysis buffer (50mM HEPES/KOH;
10% glycerol; 5mM MgAc2; 500mM KCl; 10mM imidazole; 5mM
b-mercaptoethanole; 1mM phenylmethylsulphonyl ﬂuoride (PMSF); 2mM
benzamidine), treated with lysozyme (0,2mgml 1; 30min 4 C on a spinning
wheel) and lysed by sonication (Branson Soniﬁer 250 macrotip, 10 10 s pulses with
30 s cooling in icewater). The cell extract was cleared (40,000g for 30min at 4 C)
and incubated with 1ml equilibrated NiNTA Agarose (Qiagen) at 4 C for 2 h on a
rotating wheel. The resin war transferred to a polypropylene column (Bio-Rad),
washed with CF wash buffer 1 (20mM HEPES/KOH; 10% glycerol; 5mM MgAc2;
1M KCl; 20mM imidazole; 5mM b-mercaptoethanole; 1mM PMSF; and 2mM
benzamidine), then CF wash buffer 2 (same as wash buffer 1 but 0.2M KCl) and
ﬁnally eluted with CF elution buffer (20mM HEPES/KOH; 10% glycerol; 5mM
MgAc2; 0,2M KCl; 250mM imidazole; and 5mM b-mercaptoethanole). The eluate
was loaded onto a MonoQ column (MonoQ GL 5/50 GE healthcare) a linear
gradient from 20% buffer B to 80% buffer B was applied; buffer A: (20mM HEPES/
KOH; 10% glycerol; 1mM MgAc2; and 5mM DTT), buffer B: (20mM HEPES/
KOH; 10% glycerol; 1mM MgAc2; 5mM DTT; and 1M KCl). The peak eluate
fraction was loaded to a Superose6 HR 10/30 column (GE healthcare) equilibrated
with buffer C: (20mM HEPES/KOH; 10% glycerol; 1mM MgAc2; 5mM DTT; and
0,15M KCl).
Puriﬁcation of recombinant A49/34.5 complexes. Expression and puriﬁcation
of recombinant A49/34.5 complexes and puriﬁcation was according to ref. 33 with
some modiﬁcations. Expression vector for the heterodimeric A49/A34.5 complex
was a kind gift of P. Cramer and colleagues. Full-length A49/A34.5 or truncated
A49 (amino acids 1–110 or 1–186) proteins were expressed by autoinduction in TB
(ref. 49) overnight at 18 C, harvested and resuspended in lysis buffer (50mM
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HEPES/KOH; 10% glycerol; 5mM MgAc2; 200mM KCl; 10mM imidazole; 5mM
b-mercaptoethanole; 1mM PMSF; and 2mM benzamidine), lysed by sonication
and cleared by ultracentrifugation. The cleared lysate was incubated with 1ml
equilibrated Talon afﬁnity resin (Clontech) at 4 C on a rotating wheel for 2 h. The
resin was washed in a polypropylene column (Bio-Rad), with A49 wash buffer 1
(20mM HEPES/KOH; 10% glycerol; 5mM MgAc2; 0.2M KCl; 10mM imidazole;
5mM b-mercaptoethanole; 1mM PMSF; and 2mM benzamidine) and ﬁnally
eluted with elution buffer (20mM HEPES/KOH; 10% glycerol; 5mMMgAc2; 0.2M
KCl; 150mM imidazole; and 5mM b-mercaptoethanole). The eluate was diluted
with the same volume of buffer A (20mM HEPES/KOH; 10% glycerol; 1mM
MgAc2; and 3mM DTT), loaded onto a MonoS column (MonoS GL 5/50; GE
healthcare or MonoS HR 5/5 Amersham/Pharmacia) and eluted with a linear
gradient of 10%—80% buffer B (20mM HEPES/KOH; 10% glycerol; 1mM MgAc2;
3mM DTT; 1M KCl). The C-terminal domain of A49 (amino acids 186–415; or
111–415) was puriﬁed using the Talon afﬁnity resin as described, but the anion-
exchange chromatography step was omitted.
Puriﬁcation of yeast RNA polymerase I. WT RNA Pol I and mutant polymerases
were puriﬁed from yeast strains y2423 (Pol I WT) and y2670 (Pol I D49) according
to ref. 34 with some modiﬁcations using a protein A (ProtA) afﬁnity tag. The
second largest subunit A135 is expressed as a C-terminal fusion protein with a
protein A tag.
A 20 l YPD (yeast extract, peptone, dextrose) culture was grown at 30 C to an
optical density at 600 nm (OD600) of 2–3. Cells were harvested (4,000g for 6min at
room temperature), washed with ice-cold water, resuspended in buffer 1 (0,15M
HEPES/KOH pH 7.8, 40% glycerol, 60mM MgCl2, 3mM DTT including protease
inhibitors (PI; 2mM Benzamidine, 1mM PMSF) and adjusted to a ﬁnal
concentration of 400mM (NH4)2SO4. Cell suspension was frozen in liquid
nitrogen and stored at  80 C. Subsequent steps were performed at 4 C. Thawed
cells were broken with glass beads using 10 cycles of bead beating. Glass beads and
cellular debris was removed by centrifugation (4,000g for 20min at 4 C). The
lysate was clariﬁed by ultracentrifugation (100,000g for 90min; Ti45 rotor
Beckman Coulter).
Alternatively 2 l YPD (yeast extract, peptone, dextrose) culture was grown at
30 C to an optical density at 600nm (OD600) of 1. Cells were harvested (4,000g for
6min at room temperature), washed with ice-cold water, frozen in liquid nitrogen
and stored at  20 C. Cell pellet was weighed and resuspended in 1.5ml lysis
buffer (50mM HEPES/KOH pH 7.8, 20% glycerol, 0.4M (NH4)2SO4, 40mM
MgCl2, 3mM DTT including protease inhibitors (PIs (2mM Benzamidine, 1mM
PMSF). Polymerase puriﬁcation was performed at 4 C. Cell suspension (0.7ml)
were added to 2ml reaction tubes containing 1.4 g glass beads (diameter
0.75–1mm, Roth). Cells were lysed on an IKA Vibrax VXR basic shaker with
2,200 r.p.m. at 4 C for 10min, followed by 5min cooling on ice. This procedure
was repeated four times. The cell extract was cleared from glass beads by
perforation of the cup at bottom and cap and a centrifugation step (150g, 1min,
4 C). Cell debris were removed by centrifugation at 16,000g and 4 C for 30min.
The protein content of the supernatant was determined using the Bradford assay.
Equal protein amounts (usually 1ml cell extract, 20–30mg) were incubated
with 50–75 ml of immunoglobulin-G (rabbit serum, I5006-100MG, Sigma) coupled
magnetic beads slurry (1mm BcMag, FC-102, Bioclone)50 for 1–2 h on a rotating
wheel. The beads had previously been equilibrated three times with 500 ml lysis
buffer. The beads were washed ﬁve times with 1ml buffer B1500 (20mM HEPES/
KOH pH 7.8, 1mM MgCl2, 20% glycerol, 0.1% NP40, 1x PI and 1,500mM KOAc)
three times with 1ml buffer B200 (same as B1500 but without NP40 and PIs and
with 200mM KOAc) and for elution ﬁnally resuspended in 50–100 ml buffer B200,
supplemented with 3 ml Tobacco-Etch-Virus (TEV) protease (2,6mgml 1) and
incubated for 2 h at 16 C, or overnight at 4 C, in a thermomixer (1,000 r.p.m.).
The supernatant was collected, the beads were washed twice with 50 ml B200 and
the wash steps were added to the eluted fraction. Aliquots were frozen in liquid and
stored at  80 C. 10% of the elution fraction were analysed via SDS–PAGE to
monitor the puriﬁcation success. Protein concentration was determined by
comparing the intensity of Coomassie-stained RNA polymerase subunits to the
deﬁned amounts of Coomassie-stained bovine serum albumin.
The same strategy was applied to strain y2670 from which Pol I depleted from
subunits A49/34.5 (Pol I D49) was puriﬁed. Before cells were harvested an
overnight preculture of strain y2670 was grown in Yeast extract-Peptone-Galactose
(YPG) and then shifted for 24 h to glucose containing (YPD) medium to deplete
subunit A49. Depletion of subunits A49 and A34.5 was monitored by Coomassie-
stained SDS–PAGE and western blotting (Supplementary Fig. 6a).
The initiation competent Pol I-Rrn3 complex was puriﬁed from yeast whole-cell
extracts according to ref. 34 with some modiﬁcations51.
The same strategy was applied to strain yJPF162-1a (y2670) from which Pol I
lacking subunits A49/34.5 (Pol I D49) was puriﬁed. Strain y2670 was cultivated in
YPG and then shifted for 16 h to glucose containing (YPD) medium to deplete
subunit A49 and A34.5. Depletion of subunits A49 and A34.5 was monitored by
Coomassie-stained SDS–PAGE and western blotting (Supplementary Fig. 1).
Puriﬁcation of Pol I-Rrn3 complex. The initiation competent Pol I-Rrn3 complex
was puriﬁed from whole-cell extracts of strain y2183 which was transformed with
plasmid YCplac111-GAL-Rrn3-ProtA (plasmid number 729). This strain
overexpresses Rrn3- TEV-ProtA-His7 under the control of an GAL1/10 promoter.
Puriﬁcation was performed according to ref. 51 with some modiﬁcations. A 20-l
fermentor was inoculated to an OD600B0.05 and the strain was grown overnight
(doubling time B250min) in YPR medium until the culture reached an OD600 of
1–2. Rrn3 overexpression was induced for 3 h adding 2% galactose. The cells were
harvested by centrifugation at 2,000g for 2min. Cells were washed twice with ice-
cold water and resuspended in yeast lysis buffer including 1 PIs (1ml buffer per
1 g of cell paste). The cell suspension was frozen in liquid nitrogen and stored at
 80 C. Cells were thawed on ice. All subsequent steps were performed at 4 C.
Cell suspension (250–300ml) were placed in a 400-ml stainless steel bead beating
chamber (Biospec) and glass beads (0.5mm diameter) were added to ﬁll the
chamber. Cells were disrupted using 10 cycles of bead beating for 30 s and cooling
for 90 s. The temperature of the surrounding ice/salt bath was kept at about  5 to
 10 C. Glass beads and cell debris were removed by centrifugation for 10min at
4,000g. The supernatant was centrifuged at 100,000g for 90min. The clear super-
natant was carefully removed (B300ml). The clear supernatant was dialysed
against buffer A (20% glycerol, 20mM HEPES/KOH pH 7.8, 10mM MgCl2,
0.2mM EDTA, 1mM DTT, 1PIs) to reach the conductivity of buffer A90 (buffer
A including 90mM KCl). The dialysed sample was loaded on a DEAE-Sepharose
column (13 5.2 cm), equilibrated with buffer A90, washed with 1 l buffer A90 and
proteins were eluted with buffer A350 (buffer A including 90mM KCl). The
protein-containing peak fractions (between 200 and 300ml) were dialysed against
buffer B containing 1 PIs overnight. The dialysed sample was centrifuged at
40,000g for 30min at 4 C. The pellet which contained the initiation competent Pol
I was resuspended in 2ml buffer B600 and the protein concentration was adjusted
to 2.5–5mgml 1. After centrifugation at 40,000g for 10min to remove insoluble
protein aggregates, equal protein amounts (10–20mg) were incubated with 200 ml
of immunoglobulin-G-coupled magnetic beads (1:1 slurry bead volume (100 ml);
equilibrated three times with 500ml buffer B600) for 2 h on a rotating wheel. The
beads were washed four times with 1ml buffer B1500 and then three times with
1ml buffer B200 without NP40 and PIs. Then, the beads were resuspended in
100 ml buffer B200 supplemented with 11.7 mg TEV protease, and incubated for 2 h
at 16 C under shaking with 800 r.p.m. in a thermomixer. After collection of the
supernatants, the beads were washed with 2 50ml buffer B200 and both wash
steps were added to the eluted fraction. 5–10% of the elution fraction were analysed
in an SDS–PAGE. The protein concentration was adjusted to 0.05–0.1 pmol ml 1.
In vitro trancription. In vitro transcription using tailed templates were executed as
described in ref. 34 with the exception that no preincubation was performed. 25 nM
of tailed templates were used in a total volume of 25 ml. Promoter-dependent
in vitro transcription reactions were performed according to refs 51,52 with some
modiﬁcations. In brief, 1.5ml reaction tubes (Sarstedt safety seal) were placed on
ice. 0.5–1ml template (50–100 ng DNA) was added, which corresponds to a ﬁnal
concentration of 5–10 nM per transcription reaction (25 ml reaction volume). 1–2ml
CF (0.5 to 1 pmol ml 1; ﬁnal concentration 20–40 nM) and 1–3 ml Pol I-Rrn3 (ﬁnal
concentration 4–12 nM) were added to each tube. 20mM HEPES/KOH pH 7.8
were added to a ﬁnal volume of 12.5 ml. Transcription was started adding 12.5 ml
transcription buffer 2 . The samples were incubated at 24 C for 30min at
400 r.p.m. in a thermomixer. 200 ml Proteinase K buffer (0.5mgml 1 Proteinas K
in 0.3M NaCl, 10mM Tris/HCl pH 7.5, 5mM EDTA and 0.6% SDS) was added to
the supernatant to stop transcription. The samples were incubated at 30 C for
15min at 400 r.p.m. in a thermomixer. Ethanol (700 ml) p.a. were added and mixed.
Nucleic acids were precipitated at  20 C overnight or for 30min at  80 C. The
samples were centrifuged for 10min at 12,000g and the supernatant was removed.
The precipitate was washed with 0.15ml 70% ethanol. After centrifugation, the
supernatant was removed and the pellets were dried at 95 C for 2min. RNA in the
pellet was dissolved in 12 ml 80% formamide, 0.1M TRIS-Borate-EDTA (TBE),
0.02% bromophenol blue and 0.02% xylene cyanol. Samples were heated for 2min
under vigorous shaking at 95 C and brieﬂy centrifuged. After loading on a 6%
polyacrylamide gel containing 7M urea and 1TBE RNAs were separated
applying 25 watts for 30–40min. The gel was dried after 10min rinsing in water for
30min at 80 C using a vacuum dryer. Radiolabelled transcripts are visualised using
a PhosphoImager. For quantiﬁcation, signal intensities were calculated using Multi
Gauge (Fuji).
Cryo-electron microscopy and Image Processing. Specimen preparation. The
puriﬁed Pol I complexes were cross-linked with 0.5% of glutaraldehyde for 2min.
and diluted to a ﬁnal concentration of 7 mGml 1 in a buffer containing 20mM
Hepes, pH 7.8, 100mM ammonium acetate and 2mM MgCl2. The specimen was
adsorbed for 60min. on a small piece of carbon partially ﬂoated off a mica sheet at
the surface of a Teﬂon well containing 37 ml of sample. The carbon ﬁlm was the
transferred on an EM copper grid covered by a perforated carbon ﬁlm (Quantifoil
R2/2). The grid is ﬂash frozen in liquid ethane using an automated plunger
(Vitrobot, FEI) with controlled blotting time (4 s.), blotting force (5), humidity
(95%) and temperature (20 C). The particles were imaged using a cryo-trans-
mission electron microscope (Titan Krios, FEI) equipped with a ﬁeld emission gun
operating at 300 kV and a Cs corrector. Images were recorded under low-dose
condition (total dose of 22 e Å 2) using the automated data collection software
EPU (FEI) on a 4,096 4,096 direct detector camera (Falcon II, FEI) at a mag-
niﬁcation of  59,000 resulting in a pixel size on the specimen of 0.108 nm. A total
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of 17 frames with an electron dose of 3.2 e Å 2/frame were collected and the
frames 2–8 were aligned using the optical ﬂow protocol53 and averaged for further
analysis. A high dose image (55 e Å 2), generated by summing all frames, was
used as reference for frame alignment and for particle picking.
Image processing. Particles were selected manually from a subset of images using
the boxer application in the EMAN2 software package (http://blake.bcm.tmc.edu/
EMAN2/)54. The contrast transfer function of the microscope was determined for
each micrograph using the CTFFIND3 programme55 within the frame of the
RELION software package56, and the image phases were ﬂipped accordingly. The
molecular images were subjected to reference-free classiﬁcation in RELION to
produce representative two-dimensional (2D) class averages that were used as
cross-correlation references for automated particle picking in all frames with the
gEMpicker software57. The full data set was then partitioned in 2D using RELION
to eliminate images containing contamination or bad particles. Structure
reﬁnement was done in RELION using a starting model obtained from a previously
determined 3D model of Pol I derived from 2D crystals58. Three-dimensional
reconstruction, structure reﬁnement, 3D clustering and post-processing were
carried out in RELION. The pol I dimer structure was ﬁrst reﬁned without
imposing any symmetry constrains. The twofold symmetry axis was clearly
identiﬁed on ﬁtting the atomic structures of the monomers and was oriented in the
z-direction before performing a 3D reﬁnement with symmetry imposed. The initial
rigid body ﬁtting of the atomic structure of Pol I into the cryo-EM map was
performed using gEMﬁtter59. Normal mode-based ﬂexible ﬁtting of the atomic
structure of Pol I into the cryo-EM structures was performed using iMODFIT
(ref. 60). Illustrations were prepared using the Chimera visualization software61.
Molecular images of the Pol I-Rrn3 complex were extracted from 4,121 frames,
while the WT Pol I molecule were selected from 2,934 frames.
Local resolution estimation. Local resolution estimation was performed using
the ‘ResMap’ programme62. The data set was split randomly into two halves to
obtain two reconstructions that were used to estimate the local resolution. The
maps were coloured based on the local resolution estimation using the ‘Surface
color’ tool implemented in Chimera.
Data availability. The cryo-EM maps have been deposited in the 3D-EM database
(EMBL-European Bioinformatics Institute, Cambridge, UK). The EMBD accession
code is EMD-14485 (Pol I–Rrn3).
The authors declare that the data supporting the ﬁndings of this study are
available within the article and its Supplementary Information ﬁles.
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